Alimta (Haemato Pharm)

Recall | Medicines | 17/04/2014

The parallel distributor informed its supplied customers on 04/17/2014 and asked for a stock check of the affected batches.

Name of the medicinal product Alimta 500 mg Pulver zur Herstellung eines Konzentrates zur Herstellung einer Infusionslösung
Marketing authorisation number(s) EU/1/04/290/001
Marketing authorisation holder Eli Lilly Nederland B.V

Paralleldistribution und Durchführung Rückruf:
HAEMATO PHARM GmbH
Batch number(s) C134092E, C021161E
Classification of the recall2
BASG reference number INS - 640.001 - 1086
Email

Further inquiry note